MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹1,422 Cr | ₹1,069 Cr | ₹778 Cr | ₹509 Cr | ₹335 Cr |
What is the latest Profit & Loss Account Balance ratio of MARKSANS PHARMA ?
Year | Profit & Loss Account Balance |
---|---|
Mar2025 | ₹1,422 Cr |
Mar2024 | ₹1,069 Cr |
Mar2023 | ₹778 Cr |
Mar2022 | ₹509 Cr |
Mar2021 | ₹335 Cr |
How is Profit & Loss Account Balance of MARKSANS PHARMA Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2025 | ₹1,422 Cr | 33.03 | |
Mar2024 | ₹1,069 Cr | 37.46 | |
Mar2023 | ₹778 Cr | 52.68 | |
Mar2022 | ₹509 Cr | 52.07 | |
Mar2021 | ₹335 Cr | - |
Compare Profit & Loss Account Balance of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹9,564.8 Cr | -6.7% | -17.8% | 8.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,702.0 Cr | -3.3% | -4.6% | -7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,908.0 Cr | -9% | -13.6% | 24% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,896.0 Cr | -1.1% | 7% | 8.2% | Stock Analytics | |
CIPLA | ₹119,988.0 Cr | -2% | 0.6% | -4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,122.0 Cr | -1.1% | -3.8% | -13.3% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -6.7% |
-17.8% |
8.2% |
SENSEX | -0.9% |
-4.4% |
1.6% |
You may also like the below Video Courses